Pulike Biological Engineering, Inc. (SHA:603566)

China flag China · Delayed Price · Currency is CNY
12.64
-0.28 (-2.17%)
Dec 15, 2025, 2:56 PM CST
-11.11%
Market Cap4.42B
Revenue (ttm)1.10B
Net Income (ttm)143.67M
Shares Out341.92M
EPS (ttm)0.42
PE Ratio30.83
Forward PE22.87
Dividend0.40 (3.10%)
Ex-Dividend DateOct 17, 2025
Volume6,253,295
Average Volume3,805,606
Open12.70
Previous Close12.92
Day's Range12.59 - 12.83
52-Week Range11.28 - 15.79
Beta0.37
RSI27.26
Earnings DateApr 23, 2026

About SHA:603566

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 1,551
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603566
Full Company Profile

Financial Performance

In 2024, SHA:603566's revenue was 1.04 billion, a decrease of -16.77% compared to the previous year's 1.25 billion. Earnings were 92.81 million, a decrease of -46.82%.

Financial Statements

News

There is no news available yet.